Evidence map›Paper›PMID 37058252›Full record

ReviewJournal of cancer research and clinical oncology2023

The role of Pcdh10 in neurological disease and cancer.

Yilan Zhen, Macarena Pavez, Xinying Li

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of cancer research and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Mild SARS-CoV-2 maternal infection in mice induces transient offspring neurodevelopmental aberrance.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Genetics and pathogenesis of scoliosis.North American Spine Society journal · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. [Overexpression of CDHR2 inhibits proliferation of breast cancer cells by inhibiting the PI3K/Akt pathway].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2024
    Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Yilan ZhenMenzies Institute for Medical Research, University of Tasmania, Liverpool street, Hobart, 7000, Australia.ORCID http://orcid.org/0000-0002-9357-8375
Macarena Pavez *Department of Anatomy, University of Otago, Dunedin, Otago, New Zealand. Macarena.Pavez@otago.ac.nz.
Xinying Li *Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China. xinying.li@ahmu.edu.cn.ORCID http://orcid.org/0000-0002-0751-6929
Anhui Medical University · CNUniversity of Otago · NZUniversity of Tasmania · AU

Funding

National Natural Science Foundation of China 82200668
6 · The paper itself

Abstract

backgroundProtocadherin 10 (PCDH 10), a member of the superfamily of protocadherins, is a Ca2

methodsThis paper collects and reviews relevant literature in Pubmed.

conclusionThis review describes the latest research understanding the role of Pcdh10 in neurological disease and human cancer, highlighting the importance of scrutinizing its properties for the development of targeted therapies and identifying a need for further research to explore Pcdh10 functions in other pathways, cell types and human pathologies.

Indexed as

CadherinsNeoplasmsDNA MethylationHumansPrognosisProtocadherinsCadherinsProtocadherinsCancerEpigenetic therapyMethylationNeurological diseaseProtocadherin10TumorTumor suppressor

Identifiers

PMID37058252
PMCPMC10374755
OpenAlexW4365478912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.